aA
The International Center for Settlement of Investment Disputes (ICSID) in Washington will next week start hearing a lawsuit filed by French energy group Veolia against the Lithuanian state.
Washington arbitration to open proceedings in Veolia vs Lithuania dispute next week
© AFP / Scanpix

The Energy Ministry told BNS on Friday that the main hearing in the proceedings, which would take place remotely, would be launched on March 29 and was expected to last three weeks.

The ministry would not specify when the arbitration court could announce its decision.

Meanwhile, lawyers who consulted BNS guessed that the decision could be expected in approximately a year’s time, i.e. in the spring of 2022.

As before, the proceedings will be confidential.

Veolia took Lithuania to the International Center for Settlement of Investment Disputes (ICSID) in Washington in 2016, claiming that its investment in Lithuania was undermined by unfair treatment by the country's politicians and regulatory authorities and was initially seeking 118 million euros in damages but the claim was later reduced to 79 million euros.

The hearing of this case was initially planned to be concluded in January 2020 but was adjourned until the spring of 2021 at Veolia’s request.

Lithuania, in its turn, demands more than 240 million euros from Veolia in compensation for damage done to Lithuania and consumers. In 2017, it filed a counterclaim against Veolia at the International Center for Settlement of Investment Disputes in Washington. Last year, however, the country withdrew its lawsuit and decided to go to national courts instead.

Meanwhile, Vilnius Municipality and the municipal heat supply company, Vilniaus Silumos Tinklai (VST), are seeking 560 million euros from Veolia, a former operator of the Lithuanian capital's heating sector, at the Stockholm arbitration.

BNS
It is prohibited to copy and republish the text of this publication without a written permission from UAB „BNS“.

Northway Biotech claims to have created anti-coronavirus drug (1)

Lithuanian company Northway Biotech, based in Vilnius, claims to have created an anti-coronavirus drug...

Julius Gendvilis ends his career as head of Mitnija

Julius Gendvilis is ending his career as head of Mitnija, one of the largest construction companies in...

Vilnius invites workers of big companies to get AstraZeneca jab

Vilnius authorities have invited workers from companies with more than 100 employees to get the...

Startups in Baltics: ecosystem reached breaking point and will continue growing (1)

The Baltic States are getting increasingly attractive for startups to establish. The pandemic...

New source of support for Lithuanian small and microbusinesses business

The European Investment Fund and the LCCU have signed a cooperation agreement for a guarantee...

Top news

Northway Biotech claims to have created anti-coronavirus drug (1)

Lithuanian company Northway Biotech, based in Vilnius, claims to have created an anti-coronavirus drug...

Lithuania to start vaccination of over 55s next week mass vaccination on May 31

Lithuania is planning to start administering OCIVD-19 vaccine shots to people aged 55 years and over...

1 244 new COVID-19 cases

On Thursday, 1 244 new COVID-19 cases were recorded in Lithuania. Since the beginning of the pandemic,...

FM vows to launch takeover talks as Belarusian spa's workers protest in Vilnius

Lithuania's Foreign Affairs Ministry has vowed to launch negotiations with Belarus on the takeover of...

Lithuanian citizenship restored for basketball player Brazdeikis (1)

Ignas Brazdeikis, a Lithuanian-born Canadian professional basketball player, has had his Lithuanian...